Cargando…
Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664477/ https://www.ncbi.nlm.nih.gov/pubmed/33197600 http://dx.doi.org/10.1016/j.phrs.2020.105289 |
| _version_ | 1783609854675386368 |
|---|---|
| author | Huang, Xi Zhao, Qiulong Xia, Liang Shi, Shaoqi |
| author_facet | Huang, Xi Zhao, Qiulong Xia, Liang Shi, Shaoqi |
| author_sort | Huang, Xi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7664477 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76644772020-11-16 Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ Huang, Xi Zhao, Qiulong Xia, Liang Shi, Shaoqi Pharmacol Res Letter to the Editor Published by Elsevier Ltd. 2021-01 2020-11-13 /pmc/articles/PMC7664477/ /pubmed/33197600 http://dx.doi.org/10.1016/j.phrs.2020.105289 Text en © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Huang, Xi Zhao, Qiulong Xia, Liang Shi, Shaoqi Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ |
| title | Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ |
| title_full | Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ |
| title_fullStr | Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ |
| title_full_unstemmed | Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ |
| title_short | Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ |
| title_sort | letter to the editor in response to the articles ‘lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (sars-cov-2)’ and ‘liu shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus sars-cov-2 via suppression of nf-κb signaling pathway.’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664477/ https://www.ncbi.nlm.nih.gov/pubmed/33197600 http://dx.doi.org/10.1016/j.phrs.2020.105289 |
| work_keys_str_mv | AT huangxi lettertotheeditorinresponsetothearticleslianhuaqingwenexertsantiviralandantiinflammatoryactivitiesagainstnovelcoronavirussarscov2andliushencapsuleshowsantiviralandantiinflammatoryabilitiesagainstnovelcoronavirussarscov2viasuppressionofnfkbsignalingpathway AT zhaoqiulong lettertotheeditorinresponsetothearticleslianhuaqingwenexertsantiviralandantiinflammatoryactivitiesagainstnovelcoronavirussarscov2andliushencapsuleshowsantiviralandantiinflammatoryabilitiesagainstnovelcoronavirussarscov2viasuppressionofnfkbsignalingpathway AT xialiang lettertotheeditorinresponsetothearticleslianhuaqingwenexertsantiviralandantiinflammatoryactivitiesagainstnovelcoronavirussarscov2andliushencapsuleshowsantiviralandantiinflammatoryabilitiesagainstnovelcoronavirussarscov2viasuppressionofnfkbsignalingpathway AT shishaoqi lettertotheeditorinresponsetothearticleslianhuaqingwenexertsantiviralandantiinflammatoryactivitiesagainstnovelcoronavirussarscov2andliushencapsuleshowsantiviralandantiinflammatoryabilitiesagainstnovelcoronavirussarscov2viasuppressionofnfkbsignalingpathway |